TACE治疗原发性肝癌伴门静脉癌栓研究进展  

TACE for the treatment of primary hepatocellular carcinoma associated with portal vein tumor thrombus: recent progress in research

作　　者：孙世蒙 郭应兴[2] 雷振武[2] 汪浩杰[2] SUN Shimeng GUO Yingxing LEI Zhenwu WANG Haojie(Graduate School of Qinghai University, Xining, Qinghai Province 810001, China)

机构地区：[1]青海大学研究生院,西宁810001 [2]青海大学附属医院介入科

出　　处：《介入放射学杂志》2017年第7期668-671,共4页Journal of Interventional Radiology

摘　　要：目前以TACE为基础的联合介入治疗方法 ,均可在不同程度控制原发性肝细胞癌(PHC)进展的同时达到缓解门静脉高压、解除门静脉阻塞、控制顽固性腹水、降低上消化道出血概率的目的,从而提高患者生活质量,延长生存期。该文就近年国内外TACE联合其它介入方法治疗PHC伴门静脉癌栓研究进展作一综述,以期为临床诊疗提供帮助。At present, the combined interventional therapy that is based on transcatheter arterial chemoembolization （TACE） technique can control the progression of primary hepatocellular carcinoma （PHC） in different degrees, at the same time the clinical objectives, such as relieving portal hypertension, eliminating portal vein occlusion, controlling refractory ascites and lowering upper gastrointestinal bleeding probability, can be reliably achieved. Thus, the quality of life of the patients can be effectively improved and the survival time will be reliably prolonged. This paper aims to make a comprehensive review about the medical articles concerning TACE combined with other interventional therapies for PHC complicated by portal vein tumor thrombus, which have been published both at home and abroad in recent years, in order to provide practical help for clinical diagnosis and treatment of PHC.

关 键 词：原发性肝细胞癌 门静脉癌栓 经导管动脉化疗栓塞 介入治疗 

分 类 号：R735.7[医药卫生—肿瘤]